Oramed Pharmaceuticals (ORMP) Return on Capital Employed Growth (3y) (2015 - 2026)
Oramed Pharmaceuticals (ORMP) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4,893.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2,416.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -3,782.00 |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | 1,789.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,789.00 |
| Dec 31, 2025 | 2,015.00 |
| Sep 30, 2025 | 2,809.00 |
| Jun 30, 2025 | 2,160.00 |
| Mar 31, 2025 | 1,372.00 |
| Aug 31, 2021 | 319.00 |
| Nov 30, 2019 | 378.00 |
| Aug 31, 2019 | -911.00 |
| May 31, 2019 | -4,618.00 |
| Feb 28, 2019 | -3,122.00 |
| Nov 30, 2018 | -2,461.00 |
| Aug 31, 2018 | -464.00 |
| Aug 31, 2017 | 1,852.00 |
| May 31, 2017 | -9,995.00 |
| Feb 28, 2017 | -7,778.00 |
| Nov 30, 2016 | -9,818.00 |
| Aug 31, 2016 | -10,729.00 |
| May 31, 2016 | 8,735.00 |
| Feb 29, 2016 | 4,754.00 |
| Nov 30, 2015 | 4,229.00 |